Hydroxychloroquine, a drug traditionally used to treat malaria, lupus, and rheumatoid arthritis, gained global attention during the COVID-19 pandemic for its potential antiviral properties. The hydroxychloroquine market size is projected to reach USD 1.59 billion by 2031, growing at a CAGR of 5.10% during the forecast period (2023-2031), according to Straits Research.

Get Free Request Sample Report @ https://straitsresearch.co...